Compare · ADSE vs EW
ADSE vs EW
Side-by-side comparison of ADS-TEC ENERGY PLC (ADSE) and Edwards Lifesciences Corporation (EW): market cap, price performance, sector, and recent activity on the wire.
Summary
- ADSE operates in Consumer Discretionary, while EW operates in Health Care - the two are in different parts of the market.
- EW is the larger of the two at $48.94B, about 56.6x ADSE ($864.0M).
- Over the past year, ADSE is up 2.9% and EW is up 9.3% - EW leads by 6.4 points.
- EW has hit the wire 6 times in the past 4 weeks while ADSE has been quiet.
- EW has more recent analyst coverage (25 ratings vs 7 for ADSE).
- Company
- ADS-TEC ENERGY PLC
- Edwards Lifesciences Corporation
- Price
- $11.95+1.62%
- $83.69-1.58%
- Market cap
- $864.0M
- $48.94B
- 1M return
- +8.14%
- -4.31%
- 1Y return
- +2.93%
- +9.29%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 6
- Recent ratings
- 7
- 25
ADS-TEC ENERGY PLC
ADS-TEC Energy PLC, a B2B technology company, develops, manufactures, and services intelligent battery buffered energy systems. The company supplies integrated technology platforms that enable customers to run their electric vehicle (EV) charging and energy business models in decentralized platforms. Its portfolio of ecosystem platforms provides DC-based ultra-fast chargers for EVs on power limited grids, energy storage and management solutions for commercial and industrial applications, and energy storage and management solutions for residential sector coupling applications. The company offers ChargeBox, which contains the battery and power inverters; and ChargeTrailer, a mobile high power charging system in the form of a standard truck trailer, that has a variety of integrated inverters, air-conditioners, an energy management unit, and security firewall, as well as a communication unit through mobile radio and DC-charging technology. It also provides PowerBooster, a battery energy system that boosts capacity for the charging process; Container-Systems, a custom battery system for large-scale applications as 20- or 40-foot container solutions; and rack systems. In addition, the company is developing MyPowerplant platform for residential applications. Its products are used in private homes, public buildings, commercial enterprises, industrial and infrastructure solutions, and self-sufficient energy supply systems. The company operates in Germany, Spain, Ireland, Switzerland, Austria, and other European countries. ADS-TEC Energy PLC was founded in 1980 and is based in Dublin, Ireland.
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Latest ADSE
- Profitable Electrification for Fuel Stations: ADS-TEC Energy at Uniti Expo 2026
- New Energy Model "From the Region for the Region": Utility, Industry and Citizens Invest in Local Battery Storage
- More Charging Power Than the Grid Connection Can Provide: Battery-Buffered Microgrid Unlocks New Potential for Fast Charging
- ADS-TEC Energy Appoints Kelly Nelson as Managing Director for North America
- Where Flexibility Becomes a Business Model: ADS-TEC Energy Releases Updated Investor Presentation
- ADS-TEC Energy at Hannover Messe 2026: Battery-based infrastructure as a response to volatile energy markets
- ADS-TEC Energy Reports Preliminary and Unaudited Financial Results
- ADS-TEC Energy and Elanga bring ultra-fast charging to Penske dealership in Australia
- ADS-TEC Energy at Volta-Xchange: Flexibility Is the Key to Solving Today's Grid Challenges
- ADS-TEC Energy Shows Ways Retailers Can Monetize Charging Infrastructure at EuroShop 2026
Latest EW
- Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
- CVP, EMEACLA Bruls Annette covered exercise/tax liability with 109 shares, decreasing direct ownership by 0.53% to 20,628 units (SEC Form 4) (for withholding tax)
- CVP, Chief Financial Officer Mistras Theodora was granted 99,920 shares (SEC Form 4)
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,762 worth of shares (619 units at $91.70) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TAVR Lippis Daniel J. covered exercise/tax liability with 377 shares, decreasing direct ownership by 0.93% to 40,034 units (SEC Form 4) to cover taxes
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,577 worth of shares (619 units at $91.40) as part of a pre-agreed trading plan (SEC Form 4)
- Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
- CEO Zovighian Bernard J sold $45,982 worth of shares (523 units at $87.92) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 11-K filed by Edwards Lifesciences Corporation
- SEC Form 11-K filed by Edwards Lifesciences Corporation